Comparison of 0.5mg/kg and 1.0mg/kg Suxamethonium in patients undergoing Electroconvulsive Therapy (ECT)

Comparison of 0.5mg/kg and 1mg/kg Suxamethonium in patients undergoing voluntary ECT(Electroconvulsive Therapy)

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12609000072213

Enrollment

Registered

2009-01-28

Start date

2009-02-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Patients undergoing ECT often experience postprocedure myalgia. There is also a published range of muscle relaxant doses to minimise this occurrence. It is the purpose of this study to compare the higher and lower recommended doses to see if there is a difference in postprocedure myalgia between the two doses.

Interventions

comparison two doses of suxamethonium in ECT. suxamethonium is a muscle relaxant administered intravenously at the time of ECT to reduce muscle spasms. It will be administered in this way on two consecutive occasions within a week of each other at the time of ECT. On one occassion, the dosage amount of Suxamethonium administered to participants will be 1.0mg/kg

Study design

Allocation

Randomised controlled trial

Intervention model

Crossover

Primary purpose

Prevention

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

voluntary patients already booked independently for ECT

Exclusion criteria

involuntary patient or patients deemed unable to give consent

Outcome results